OPTIM MUJER Trademark

Trademark Overview


On Wednesday, January 3, 2024, a trademark application was filed for OPTIM MUJER with the United States Patent and Trademark Office. The USPTO has given the OPTIM MUJER trademark a serial number of 98340004. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, May 2, 2024. This trademark is owned by Pharmadel, LLC. The OPTIM MUJER trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements
optim mujer

General Information


Serial Number98340004
Word MarkOPTIM MUJER
Filing DateWednesday, January 3, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, May 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary and nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmadel, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew Castle, DE 19720

Trademark Events


Event DateEvent Description
Wednesday, January 3, 2024NEW APPLICATION ENTERED
Thursday, April 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 2, 2024NON-FINAL ACTION WRITTEN
Thursday, May 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2024ASSIGNED TO EXAMINER
Thursday, May 2, 2024NON-FINAL ACTION E-MAILED